Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.

Bussmann H, Wester CW, Wester CN, Lekoko B, Okezie O, Thomas AM, DeGruttola SM, Makhema J, Essex M, Marlink RG.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):269-73.

PMID:
17450102
2.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
3.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
4.

Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts.

Ford N, Mofenson L, Kranzer K, Medu L, Frigati L, Mills EJ, Calmy A.

AIDS. 2010 Jun 19;24(10):1461-70. doi: 10.1097/QAD.0b013e32833a2a14. Review.

PMID:
20479637
5.

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

Ford N, Calmy A, Mofenson L.

AIDS. 2011 Nov 28;25(18):2301-4. doi: 10.1097/QAD.0b013e32834cdb71. Review.

PMID:
21918421
6.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
7.

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

Ford N, Mofenson L, Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Shaffer N, Renaud F.

AIDS. 2014 Mar;28 Suppl 2:S123-31. doi: 10.1097/QAD.0000000000000231. Review.

PMID:
24849471
8.

The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?

Martin F, Taylor GP.

J Antimicrob Chemother. 2009 Nov;64(5):895-900. doi: 10.1093/jac/dkp303. Epub 2009 Aug 25. Review.

PMID:
19706669
9.

Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.

Senise JF, Castelo A, Martínez M.

AIDS Rev. 2011 Oct-Dec;13(4):198-213. Review.

PMID:
21975356
10.

Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.

Patel RC, Onono M, Gandhi M, Blat C, Hagey J, Shade SB, Vittinghoff E, Bukusi EA, Newmann SJ, Cohen CR.

Lancet HIV. 2015 Nov;2(11):e474-82. doi: 10.1016/S2352-3018(15)00184-8. Epub 2015 Oct 22. Review.

11.

Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy: A Systematic Review and Meta-Analysis of Randomized Trials.

Ford N, Shubber Z, Pozniak A, Vitoria M, Doherty M, Kirby C, Calmy A.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):422-9. doi: 10.1097/QAI.0000000000000606. Review.

PMID:
25850607
12.

Gender differences in the treatment of HIV infection.

Floridia M, Giuliano M, Palmisano L, Vella S.

Pharmacol Res. 2008 Sep-Oct;58(3-4):173-82. doi: 10.1016/j.phrs.2008.07.007. Epub 2008 Jul 30. Review.

PMID:
18708144
13.

Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.

Dabaghzadeh F, Khalili H, Ghaeli P, Dashti-Khavidaki S.

Expert Opin Pharmacother. 2012 Dec;13(18):2613-24. doi: 10.1517/14656566.2012.742887. Epub 2012 Nov 10. Review.

PMID:
23140169
14.

A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications.

Gaida R, Truter I, Grobler C, Kotze T, Godman B.

Expert Rev Anti Infect Ther. 2016;14(4):377-88. doi: 10.1586/14787210.2016.1157469. Review.

PMID:
26900637
15.
16.

Neuropsychiatric complications of efavirenz therapy: suggestions for a new research paradigm.

Sütterlin S, Vögele C, Gauggel S.

J Neuropsychiatry Clin Neurosci. 2010 Fall;22(4):361-9. doi: 10.1176/appi.neuropsych.22.4.361. Review.

PMID:
21037119

Supplemental Content

Support Center